adoseofreality.org
Monoclonal antibody holds promise of reducing learning, memory …
Chronic learning and memory problems that plague patients with schizophrenia may have a worthy foe in a monoclonal antibody that also holds promise in the fight against cancer and is already used to treat a rare disorder … Share this:Click to share on Pinterest (Opens in new window)Click to share on Pocket (Opens in new window)Click to share on WhatsApp (Opens in new window)Click to share on Facebook (Opens in new window)Click to share on Tumblr (Opens in new window)Click to share on LinkedIn (Opens in new window)Click to share on Telegram (Opens in new window)Click to share on Twitter (Opens in new window)Click to share on Skype (Opens in new window)Click to share on Reddit (Opens in new window)Click to print (Opens in new window)Click to email this to a friend (Opens in new window)Like this:Like Loading...